James Berrill

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels

James Berrill, M. Sadlier, Kerenza Hood et al. · Journal of Crohn s and Colitis · 2014 · 121 citations

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub‐clinical inflammation and the impact on clinical assessment of disease activity

James Berrill, John T. Green, Kerenza Hood et al. · Alimentary Pharmacology & Therapeutics · 2013 · 95 citations · Full text

An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease

James Berrill, John Gallacher, Kerenza Hood et al. · Neurogastroenterology & Motility · 2013 · 64 citations

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text